Clinical Trials Directory

Trials / Completed

CompletedNCT00919386

Ureteral Stent Size Measurement Study

Three Methods of Ureteral Stent Measurement: Which Method Improves Quality of Life After Ureteral Stenting?

Status
Completed
Phase
Study type
Observational
Enrollment
17 (actual)
Sponsor
CAMC Health System · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

To examine a patient's quality of life using three methods for measuring stent size: (a) direct measurement, (b) patient height, and (c) a standardized formula. The intent of the study is to show if there is a difference in a patient's quality of life, postoperative symptoms, pain medication and anticholinergic use by using one of these specific methods for stent size determination. No method is interventional in this study.

Detailed description

Ureteral stent placement is common in Urologic practice and many studies have been done looking at factors to improve stent related symptoms, but few have used a validated questionnaire to assess these symptoms affect on quality of life.We plan to prospectively randomize patients to three separate techniques such as (a) direct measurement,(b) patient height, and (c) a standardized formula for the determination of stent size. Using a validated questionnaire, the Ureteral Stent Symptoms Questionnaire (USSQ), we will assess whether there is a difference in outcome measures such as patient quality of life, need for pain medications and anticholinergics, and in postoperative symptoms based on one of these techniques. The USSQ was developed by Joshi et al to assess the impact of health-related quality of life issues related to ureteral stents. Data from USSQ questionnaire will be collected 7-10 days post-operatively as well as 4 weeks post-op and then this will be aggregated for our outcome measures to determine which method of stent size give better outcomes.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2009-06-12
Last updated
2015-07-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00919386. Inclusion in this directory is not an endorsement.